FDA Investigator Andrew S Limson
Andrew S Limson has conducted inspections on 1 sites in 1 countries as of 20 Aug 2021. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
1
Last Inspection Date:
20 Aug 2021
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Andrew S Limson:
Adam R Cooke,
Alan P Kurtzberg,
Amanda L Fyles,
Amir Alavi,
Bichsa T Tran,
Binh T Nguyen,
Bryan A Galvez,
Calvin B Koerner,
Carla J Lundi,
Caryn M Everly,
Caryn M Mcnab,
Comyar Shoghi,
Dyana K Stone,
Frederick L Fricke,
Gregory A Berg,
Janet D Blount,
Jeffery A Johnson,
Jennifer M Gogley,
Joe X Phillips,
Joey V Quitania,
John A Gonzalez,
Joseph X Phillips,
Katherine E Jacobitz,
Kham Phommachanh,
Kim Lthomas Cruse,
Linda F Murphy,
Marco S Esteves,
Marcus F Yambot,
Mariza M Jafary,
Mihaly S Ligmond,
Omotunde O Osunsanmi,
Prabhu P Raju,
Raymond T Oji,
Sangeeta M Khurana, PhD,
Santiago Gallardo Johnson,
Shannon B Ruelle,
Sparky L Bartee,
Terri L Dodds,
Thomas J Arista,
Uttaniti Limchumroon (Tom),
Virgilio F Pacio, CSO,
Walden H Lee,
Yumi J Hiramine
Andrew S Limson's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2000 | FDA 483 | Teva Parenteral Medicines, Inc. - Form 483, 2000-02-25 |
February, 2000 | EIR | Teva Parenteral Medicines, Inc. - EIR, 2000-02-25 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more